本页面由Tiger Trade Technology Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

44.18
+0.89002.06%
盘后44.180.00000.00%19:30 EDT
成交量:124.96万
成交额:5,492.03万
市值:47.98亿
市盈率:-23.88
高:44.68
开:43.54
低:43.00
收:43.29
52周最高:48.40
52周最低:13.69
股本:1.09亿
流通股本:8,817.09万
量比:0.94
换手率:1.42%
股息:- -
股息率:- -
每股收益(TTM):-1.8502
每股收益(LYR):-1.6302
净资产收益率:-38.03%
总资产收益率:-25.03%
市净率:10.71
市盈率(LYR):-27.10

数据加载中...

2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/16

重要事件披露

Form 8-K/A - Current report: [Amend]
2026/07/13

重要事件披露

Form 8-K - Current report
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/07

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/26

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/26

重要事件披露

Form 8-K - Current report